Targeting synovial fibroblast proliferation in rheumatoid arthritis (TRAFIC): an open-label, dose-finding, phase 1b trial (2021)
Attributed to:
MICA: Targeting the RA synovial fibroblast via cyclin dependent kinase inhibition - a phase IIa study
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/ s2665-9913(21)00061-8
Publication URI: http://dx.doi.org/10.1016/ s2665-9913(21)00061-8
Type: Journal Article/Review
Volume: 3
Parent Publication: LANCET RHEUMATOLOGY
Issue: 5